Integrated phylogeny of the human brain and pathobiology of Alzheimer's disease: A unifying hypothesis

SV Ovsepian, VB O'Leary, C Hoschl, L Zaborszky - Neuroscience letters, 2021 - Elsevier
The disproportionate evolutionary expansion of the human cerebral cortex with
reinforcement of cholinergic innervations warranted a major rise in the functional and …

[HTML][HTML] Alzheimer's Disease and Its Possible Evolutionary Origin: Hypothesis

JF Whitfield, K Rennie, B Chakravarthy - Cells, 2023 - mdpi.com
The enormous, 2–3-million-year evolutionary expansion of hominin neocortices to the
current enormity enabled humans to take over the planet. However, there appears to have …

The Future: Moving from Phenotypically Defined Diseases Toward Pathophysiological Systems

MR Keezer, PR Bauer, JW Sander - Canadian Journal of …, 2024 - cambridge.org
The traditional approach in medicine is to define diseases phenotypically based on clinically
demonstrable signs and symptoms. When our understanding of the nervous system was …

[HTML][HTML] Exploring the pathogenesis of Alzheimer disease in basal forebrain cholinergic neurons: converging insights from alternative hypotheses

XQ Chen, WC Mobley - Frontiers in neuroscience, 2019 - frontiersin.org
Alzheimer disease (AD) represents an oncoming epidemic that without an effective
treatment promises to exact extraordinary financial and emotional burdens (Apostolova …

Inhomogeneous distribution of A lzheimer pathology along the isocortical relief. Are cortical convolutions an A chilles heel of evolution?

T Arendt, M Morawski, U Gärtner, N Fröhlich… - Brain …, 2017 - Wiley Online Library
Alzheimer's disease (AD) is neuropathologically characterized by neuritic plaques and
neurofibrillary tangles. Progression of both plaques and tangles throughout the brain follows …

Neurobiology of Alzheimer's disease: integrated molecular, physiological, anatomical, biomarker, and cognitive dimensions

J Raskin, J Cummings, J Hardy… - Current Alzheimer …, 2015 - ingentaconnect.com
Background: Alzheimer's disease (AD), the most common form of dementia, is a progressive
neurodegenerative disorder with interrelated molecular, physiological, anatomical …

Alzheimer's disease: the size of the problem, clinical manifestation and heterogeneity

H Förstl - Alzheimer's Disease—From Basic Research to Clinical …, 1998 - Springer
Age is the major demographic risk factor for the development of Alzheimer's disease (AD)
and the ageing of our society has contributed to the growing importance of AD. The problem …

Is sporadic Alzheimer′ s disease a developmental disorder?

T Arendt, J Stieler, U Ueberham - Journal of neurochemistry, 2017 - Wiley Online Library
Alzheimer′ s disease (AD) is a neurodegenerative disorder of higher age that specifically
occurs in human. Its clinical phase, characterized by a decline in physiological …

Regional mosaic genomic heterogeneity in the elderly and in Alzheimer's disease as a correlate of neuronal vulnerability

T Arendt, MK Brückner, A Lösche - Acta neuropathologica, 2015 - Springer
Alzheimer's disease (AD) is a neurodegenerative disorder characterized by fibrillary
aggregates of Aβ peptide and tau protein. The distribution of these pathological hallmarks …

Amyloid-β, tau, and the cholinergic system in Alzheimer's disease: Seeking direction in a tangle of clues

A Majdi, S Sadigh-Eteghad… - Reviews in the …, 2020 - degruyter.com
The link between histopathological hallmarks of Alzheimer's disease (AD), ie amyloid
plaques, and neurofibrillary tangles, and AD-associated cognitive impairment, has long …